NEHP, an experienced provider to FDA regulated industries and a pioneer in the modularization of process piping for semiconductor production has named Peter Sbrollini to the position of Director, Life Sciences Business Development. Sbrollini will oversee NEHP’s ongoing expansion into the life sciences industry; pharmaceutical, biotechnology and related industries.
“Peter has a proven track record in the industry,” said NEHP president Adam Tarr. “We’ve established ourselves as a leader in microelectronics and are building a solid portfolio in life sciences. With Peter’s industry knowledge and experience, I’m confident we can reach the decision makers who will recognize our value-based approach and commitment to highest quality.”
Peter Sbrollini has a commitment to providing solutions to critical process needs and worked for more than 20 years marketing specialized equipment to the pharmaceutical and life science industries. Past clients have included Pfizer, Schering, Bristol Myers Squibb and Amgen. Sbrollini is a member of ISPE and NACE. He holds a BS in marketing from the University of Bridgeport and an MBA in marketing from the University of Hartford.
About NEHP Inc.
Founded in 2000 and based in Vermont, USA, NEHP is a pioneer in the field of process utilities and products for the semiconductor, solar and life sciences industries. NEHP is considered a leader because the company was the first to introduce our process for modularization in the semiconductor industry and were awarded a patent for this process in 2006.
NEHP delivers process utility solutions with cost savings, faster installation and unsurpassed quality to worldwide customers that include Applied Materials, IBM, Intel, Nikon, Vishay, Fluor, Amgen, Stryker, Bristol-Myers Squibb and Wyeth Pharmaceuticals.
All NEHP product and field work are compliant with SEMI, cGMP, and BPE industry standards and regulations. For more information please visit www.nehp.com.
